Skip to main content
OpenTrials
Completed

NCT Number: NCT00729196

A Trial of Two Diets for Weight and Diabetes Management

The purpose of this study is to determine whether a low-fat or low-glycemic load diet is more effective for controlling weight and blood glucose in persons with type 2 diabetes.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of Pennsylvania, Center for Weight and Eating Disorders

Philadelphia, Pennsylvania, 19104-3309, United States

About this study

This research is a randomized controlled trial to compare long-term outcomes behavioral weight loss interventions that include either low-fat or low-glycemic load dietary instruction. Targets for energy intake and expenditure, and behavioral skills taught, are identical across the two diets. Additionally, both treatments include 20 weekly group sessions, followed by 10 every-other-week sessions. Participants are overweight and obese adults with type 2 diabetes. The primary outcomes are changes in weight and glycated hemoglobin. Those randomized to the low-glycemic load diet are expected to achieve greater weight losses and maintain better glycemic control at the end of treatment (i.e., week 40) and after 1 year of no-treatment follow-up (i.e., week 92).

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Type 2 Diabetes Mellitus
  • Body mass index (BMI) of 27 to 45 kg/m2 with weight </= 136 kg (300 lbs.
  • Capacity to provide written informed consent
  • Systolic blood pressure between 90 and 160 mm Hg, inclusive.
  • Diastolic blood pressure between 65 and 100 mm Hg, inclusive.
  • Resting heart rate between 65 and 90 beats per minute, inclusive.

Exclusion criteria

  • a recent (i.e., within 1 year) myocardial infarction
  • unstable angina
  • malignant arrhythmias
  • history of cerebrovascular, renal, or hepatic disease
  • history of seizures
  • protein wasting diseases (e.g., Cushing's syndrome)
  • uncontrolled hypertension (> 160/100 mm Hg)
  • type 1 diabetes
  • uncontrolled thyroid disease
  • pregnancy or lactation
  • electrolyte abnormalities
  • clinically significant psychosocial impairment (principally, major depression)
  • treatment with steroids

Treatment and study plan

Lifestyle Modification

Behavioral

Weekly group therapy for 20 weeks, followed by bi-weekly group therapy for 20 weeks

Primary outcomes

  1. Percent change in weight

    Time frame: 92 weeks

Secondary outcomes

  1. Change in HbA1c

    Time frame: 92 weeks

Sponsors and collaborators

Lead sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Nih

Collaborators

  • University of Pennsylvania

Registry information

Acronym: Two-for-2

Important dates

Study start
2005
Primary completion
2010
Study completion
2010
First posted
Aug 7, 2008
Registry last updated
Feb 1, 2011

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.